Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share (ANRO)

Historical Holders from Q1 2024 to Q3 2025

Symbol
ANRO on NYSE
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
32.6M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
16.8M
Holdings value
$67.4M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
74
Number of buys
26
Number of sells
-35
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share (ANRO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Commodore Capital LP 9.8% $12.8M 3.19M Commodore Capital LP 20 Oct 2025
ARMISTICE CAPITAL, LLC 7.05% $4.59M 2M Armistice Capital, LLC 30 Jun 2025
PERCEPTIVE ADVISORS LLC 7.3% $7.72M 1.99M Perceptive Advisors LLC 03 Oct 2025
Point72 Asset Management, L.P. 7% -20% $4.35M -$1.03M 1.91M -19.2% Steven A. Cohen 31 Mar 2025
K2 HealthVentures Equity Trust LLC 5.6% $3.69M 1.62M K2 HealthVentures Equity Trust LLC 13 Jan 2025
FMR LLC 4.7% $2.89M 1.27M FMR LLC 31 Dec 2024
BlackRock, Inc. 2.1% $1.23M 561K BlackRock, Inc. 30 Jun 2025

Institutional Holders of Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share (ANRO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 16.8M $67.4M -$1.67M $4.02 74
2025 Q2 17.3M $38.1M -$7.94M $2.20 78
2025 Q1 20.8M $45M -$4.17M $2.16 83
2024 Q4 22.5M $95.3M -$45.5M $4.23 77
2024 Q3 22.9M $265M +$37M $11.44 75
2024 Q2 18.6M $199M +$25.8M $10.69 58
2024 Q1 16M $245M +$245M $15.35 52